Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
-
2441
-
2442
-
2443
-
2444
-
2445
-
2446
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2447
-
2448
-
2449
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2450
-
2451
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2452
-
2453
-
2454
-
2455
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2456
-
2457
-
2458
-
2459
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2460
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: